SG/CALL/AMGEN/400/0.1/21.03.25 Share Price

DE000SU6V4J6

Market Closed - Boerse Frankfurt Warrants 20:37:50 21/06/2024 BST
0.54 ^EUR	-1.82%

Current month	-6.78%
1 month	-26.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

US FDA approves Roche's drug for a chronic blood disorder	06-21	RE
Amgen : Bringing Cardiovascular Care to the Heart of Communities	06-20	PU
Amgen : Continues to Propel BiTE® Technology Innovation	06-20	PU
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	06-14	DJ

More news

Quotes 5-day view

Date	Price	Change
21/06/24	0.55	0.00%
20/06/24	0.55	+14.58%
19/06/24	0.48	-4.00%
18/06/24	0.5	0.00%
17/06/24	0.5	+19.05%

Real-time Boerse Frankfurt Warrants

Last update June 21, 2024 at 08:37 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Société Générale
WKN	SU6V4J
ISIN	DE000SU6V4J6
Date issued	10/01/2024
Strike	400 $
Maturity	21/03/2025 (272 Days)
Parity	10 : 1
Emission price	0.93 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.26 €
Lowest since issue	0.21 €
Spread	0.02 €
Spread %	3.70%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company